This Article is no longer available, this page is showing similar articles.

Food, Drugs, Healthcare, Life Sciences

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

CMS Releases The Proposed 2027 Medicare Advantage And Part D Rules

Last week, the Centers for Medicare & Medicaid Services (CMS) released its proposed Contract Year 2027 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program (Proposed 2027 Rules).

United States Healthcare

M

Mintz

Virtual And Digital Health Digest

This digest covers key virtual and digital health regulatory and public policy developments during October and early November 2025 from the United States, United Kingdom, and European Union.

Worldwide Healthcare

AP

Arnold & Porter

Digital Health Technologies Use In Clinical Trials: Support From MAHA And Defined Expectations From FDA's Final Guidance

Digital health technologies (DHT) are a key aspect of U.S. Health & Human Services (HHS) Secretary Robert F. Kennedy Jr.'s Make America Healthy Again (MAHA) agenda.

United States Healthcare

FL

Foley & Lardner

The Weekly Hill Update - December 01, 2025

Below is this week's congressional update by BakerHostetler's Federal Policy team. We'll continue to post in weeks when both chambers of Congress are in session.

United States Healthcare

B

BakerHostetler

No Doctor, No Problem: The Benefits Of Innovation Expanding OTC Drug Access

United States Healthcare

N

NERA

$285 Million FCA Trebled Damages Award Against Caremark Sparks Appeal

United States Healthcare

AP

Arnold & Porter

The 2026 OPPS Final Rule: Hospitals Now At A Decision Point Regarding Drug Acquisition Cost Survey

United States Healthcare

KG

K&L Gates LLP

New Medical Device And IVD Registration And Transparency Requirements To Apply In 2026

United States Healthcare

AP

Arnold & Porter

Financing And Exit Strategies In Life Sciences: Aligning Capital With Compliance And IP Value

United States Healthcare

DM

Duane Morris LLP

What 340B Hospitals Need To Know About CMS's CY 2026 OPPS Final Rule

United States Healthcare

PL

Polsinelli LLP

Congress Introduces Bill To Create National Biomanufacturing Center Of Excellence

United States Healthcare

SM

Sheppard Mullin Richter & Hampton

Ameri̇ka Bi̇rleşi̇k Devletleri̇ Sağlik Kuruluşlari İçi̇n Göçmenli̇k Strateji̇si̇ Yasal Ri̇skten Strateji̇k Avantaja

United States Healthcare

AL

Akalan Law Firm

Recent Updates Transforming Plan Sponsor Relationships With Pharmacy Benefit Managers

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

From Operations To Assets: Quantifying The ROI Of AI In Financial Due Diligence

United States Healthcare

AM

Alvarez & Marsal

See more

Webinars

See More

Recorded on 24 Jun 2025 | 3:00 PM

(2nd Session) 2025 Global In-House Counsel Survey Report: Unique Insights into the Global In-House Counsel Profession

IC

In-House Counsel Worldwide

Recorded on 24 Jun 2025 | 9:00 AM

(1st Session) 2025 Global In-House Counsel Survey Report: Unique Insights into the Global In-House Counsel Profession

IC

In-House Counsel Worldwide

Recorded on 30 Apr 2025 | 2:00 PM

Mondaq | 2025 Law Firm Data Landscape Report

mm

Mondaq

Recorded on 21 Jan 2025 | 3:00 PM

2025 Canadian In-House Counsel Report: Unparalleled Insights into Canada's In-House Profession from CCCA | Mondaq

TC

CBA In-House Lawyers

Highlighted Content

Plausibility At The EPO – An Update On G2/21

United States Healthcare

D

Dehns

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In The United States Today?

United States Healthcare

D

Dehns

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In Europe Today?

United States Healthcare

D

Dehns

How Good Does A Copy Need To Be?

United States Healthcare

D

Dehns

Supplementary Protection Certificates – European Patent Term Extensions

United States Healthcare

D

Dehns

How Much Experimental Data Is Needed For Patent Applications In Europe?

United States Healthcare

D

Dehns

The Silent Treatment: The EPO's Approach To Non-therapeutic Methods Encompassing Therapeutic Effects

United States Healthcare

D

Dehns

Implications Of The Genetic Technology (Precision Breeding) Bill On The Life Science IP Sector

United States Healthcare

D

Dehns

Protection For Plant Varieties In Europe And The UK Post-Brexit

United States Healthcare

D

Dehns

Best Practice For Invention Harvesting

United States Healthcare

D

Dehns

Healthcare

CMS Releases The Proposed 2027 Medicare Advantage And Part D Rules

Last week, the Centers for Medicare & Medicaid Services (CMS) released its proposed Contract Year 2027 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program (Proposed 2027 Rules).

United States Healthcare

M

Mintz

Virtual And Digital Health Digest

This digest covers key virtual and digital health regulatory and public policy developments during October and early November 2025 from the United States, United Kingdom, and European Union.

Worldwide Healthcare

AP

Arnold & Porter

Digital Health Technologies Use In Clinical Trials: Support From MAHA And Defined Expectations From FDA's Final Guidance

Digital health technologies (DHT) are a key aspect of U.S. Health & Human Services (HHS) Secretary Robert F. Kennedy Jr.'s Make America Healthy Again (MAHA) agenda.

United States Healthcare

FL

Foley & Lardner

The Weekly Hill Update - December 01, 2025

United States Healthcare

B

BakerHostetler

Illinois Becomes The First State To Regulate The Use Of AI Mental Health Therapy Services

United States Technology

SM

Sheppard Mullin Richter & Hampton

No Doctor, No Problem: The Benefits Of Innovation Expanding OTC Drug Access

United States Healthcare

N

NERA

A Look At Current Healthtech VC Trends

United States Commercial

FL

Foley & Lardner

$285 Million FCA Trebled Damages Award Against Caremark Sparks Appeal

United States Healthcare

AP

Arnold & Porter

The 2026 OPPS Final Rule: Hospitals Now At A Decision Point Regarding Drug Acquisition Cost Survey

United States Healthcare

KG

K&L Gates LLP

See more

Food and Drugs Law

CMS Releases The Proposed 2027 Medicare Advantage And Part D Rules

Last week, the Centers for Medicare & Medicaid Services (CMS) released its proposed Contract Year 2027 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program (Proposed 2027 Rules).

United States Healthcare

M

Mintz

New York State Enacts Cash Acceptance Law

With the signing of New York Senate Bill S4153A by Gov. Kathy Hochul, New York state has enacted a sweeping requirement for "retail establishments" and "food stores" to accept cash payments for in-person transactions.

United States Finance

HK

Holland & Knight

European Commission Secures "Pay For Delay" Victory In Top EU Court Ruling

The Court of Justice of the European Union (CJEU) has upheld a General Court (GC) judgment that sided with the European Commission (EC)'s decision to fine Teva and Cephalon for a "pay for delay" pharmaceutical patent settlement agreement.

European Union Anti-trust

AO

A&O Shearman

The 2026 OPPS Final Rule: Hospitals Now At A Decision Point Regarding Drug Acquisition Cost Survey

United States Healthcare

KG

K&L Gates LLP

EU Geopolitical Risk Update - Key Policy & Regulatory Developments No. 123

European Union Strategy

JD

Jones Day

California Regulators Move Toward Classifying All P,p'-Bisphenol Chemicals As Causing Reproductive Toxicity Under Proposition 65

United States Energy

SH

Shook, Hardy & Bacon

Financing And Exit Strategies In Life Sciences: Aligning Capital With Compliance And IP Value

United States Healthcare

DM

Duane Morris LLP

Essentials For Co-Manufacturer Agreements

United States Consumer

LL

Loeb & Loeb LLP

What 340B Hospitals Need To Know About CMS's CY 2026 OPPS Final Rule

United States Healthcare

PL

Polsinelli LLP

See more

Life Sciences, Biotechnology & Nanotechnology

New Medical Device And IVD Registration And Transparency Requirements To Apply In 2026

On 27 November 2025, the European Commission published a notice in the Official Journal confirming that the first four modules of the European database on medical devices (EUDAMED) are fully functional.

United States Healthcare

AP

Arnold & Porter

California Regulators Move Toward Classifying All P,p'-Bisphenol Chemicals As Causing Reproductive Toxicity Under Proposition 65

A new California initiative aims to classify all p,p'-bisphenol chemicals, including ethers and esters of p,p'-bisphenols, bisphenol AF...

United States Energy

SH

Shook, Hardy & Bacon

Financing And Exit Strategies In Life Sciences: Aligning Capital With Compliance And IP Value

Financing and exit transactions in the life sciences industry differ fundamentally from those in traditional technology or manufacturing sectors.

United States Healthcare

DM

Duane Morris LLP

Sector Focus: AI-Driven Tech, Healthcare And Financial Services Lead Dealmaking

United States Finance

D

Dechert

Congress Introduces Bill To Create National Biomanufacturing Center Of Excellence

United States Healthcare

SM

Sheppard Mullin Richter & Hampton

From Operations To Assets: Quantifying The ROI Of AI In Financial Due Diligence

United States Healthcare

AM

Alvarez & Marsal

Genesis Mission Seeks To Bolster Scientific Discovery, National Security, Energy Dominance

United States Healthcare

HK

Holland & Knight

Can A Chemically Synthesised Medicine Be Authorised As A Generic Of A Biological Medicine? And Who Can Challenge This?

United States Healthcare

AP

Arnold & Porter

BsUFA IV Is Coming: FDA Calls For Public Input

United States Healthcare

HP

Hyman, Phelps, & McNamara

See more

Latest Videos

See more

Critical Medical Device Series: Part X Balancing Risk And Innovation: Fraud And Abuse Trends For MedTech (Video)

AP

Arnold & Porter

Strategic Synergy At Atlantic Health: Saad Ehtisham On How Leadership Alignment Fuels Transformation (Video)

AM

Alvarez & Marsal

Album 9: Track 12 Steady On – Trilliant Health (Part 2) (Podcast)

PL

Polsinelli LLP

Navigating Health Plan M&A: Strategies For Success In The Medicare Advantage Market (Podcast)

RG

Ropes & Gray LLP

Navigating Women's Health With Rachel Welch (Video)

OK

Offit Kurman

Upcoming Events

Healthcare Innovation: Strategic Adaption To The New Policy Landscape

United States Healthcare

FH

Foley Hoag LLP

2026 JP Morgan Healthcare Conference Reception

United States Healthcare

SM

Sheppard Mullin Richter & Hampton

State-Level Challenges And Initiatives Amid FDA Enforcement Discretion

United States Healthcare

HK

Holland & Knight

All In The Family - After The Wedding: AMC And Community Hospital Affiliations In Practice - American Health Law Association Academic Medical Centers Conference

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

Pharmaceutical EHS Counsel Roundtable

United States Healthcare

BD

Beveridge & Diamond

ATA EDGE 2025 Policy Conference

United States Healthcare

FL

Foley & Lardner

Amy Hunsberger To Speak At PLI’s Hot Topics In Health Care Law 2025

United States Healthcare

MP

Manatt, Phelps & Phillips LLP

The Mass League Health Center Compliance Academy: Pharmacy/340B

United States Healthcare

FH

Foley Hoag LLP

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More